{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:30:05Z","timestamp":1762867805795},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T00:00:00Z","timestamp":1557878400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T00:00:00Z","timestamp":1557878400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"KAKENHI","award":["JP18K08531"],"award-info":[{"award-number":["JP18K08531"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s00592-019-01362-1","type":"journal-article","created":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T19:46:17Z","timestamp":1557949577000},"page":"31-39","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Xanthine oxidoreductase activity correlates with vascular endothelial dysfunction in patients with type 1 diabetes"],"prefix":"10.1007","volume":"57","author":[{"given":"Kahori","family":"Washio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiki","family":"Kusunoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taku","family":"Tsunoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Osugi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mana","family":"Ohigashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayo","family":"Murase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiro","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosuke","family":"Konishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyuki","family":"Katsuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuyoshi","family":"Namba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidenori","family":"Koyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,15]]},"reference":[{"key":"1362_CR1","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1172\/JCI118709","volume":"97","author":"HO Steinberg","year":"1996","unstructured":"Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G, Baron AD (1996) Obesity\/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest 97:2601\u20132610","journal-title":"J Clin Invest"},{"key":"1362_CR2","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/ajh.2011.55","volume":"24","author":"H Tomiyama","year":"2011","unstructured":"Tomiyama H, Higashi Y, Takase B et al (2011) Relationships among hyperuricemia, metabolic syndrome, and endothelial function. Am J Hypertens 24:770\u2013774","journal-title":"Am J Hypertens"},{"key":"1362_CR3","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1210\/jc.2010-2363","volume":"96","author":"GV C\u00e9","year":"2011","unstructured":"C\u00e9 GV, Rohde LE, da Silva AM, Pu\u00f1ales MK, de Castro AC, Bertoluci MC (2011) Endothelial dysfunction is related to poor glycemic control in adolescents with type 1 diabetes under 5\u00a0years of disease: evidence of metabolic memory. J Clin Endocrinol Metab 96:1493\u20131499","journal-title":"J Clin Endocrinol Metab"},{"key":"1362_CR4","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1056\/NEJMoa022314","volume":"348","author":"DM Nathan","year":"2003","unstructured":"Nathan DM, Lachin J, Cleary P et al (2003) Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus. N Engl J Med 348:2294\u20132303","journal-title":"N Engl J Med"},{"key":"1362_CR5","doi-asserted-by":"crossref","first-page":"686","DOI":"10.2337\/dc15-1990","volume":"39","author":"Diabetes Control and Complications Trial (DCCT)\/Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group","year":"2016","unstructured":"Diabetes Control and Complications Trial (DCCT)\/Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group (2016) Intensive diabetes treatment and cardiovascular outcomes in type 1 diabetes: the DCCT\/EDIC study 30-year follow-up. Diabetes Care 39:686\u2013693","journal-title":"Diabetes Care"},{"key":"1362_CR6","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/1475-2840-12-156","volume":"12","author":"O Schnell","year":"2013","unstructured":"Schnell O, Cappuccio F, Genovese S, Standl E, Valensi P, Ceriello A (2013) Type 1 diabetes and cardiovascular disease. Cardiovasc Diabetol 12:156","journal-title":"Cardiovasc Diabetol"},{"key":"1362_CR7","unstructured":"The Japanese Circulation Society. Guidelines for non-invasive vascular function test. \nhttp:\/\/www.j-circ.or.jp\/guideline\/index.htm\n\n. Accessed 5 Jan 2019"},{"key":"1362_CR8","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1161\/01.ATV.20.9.2032","volume":"20","author":"JP Cooke","year":"2000","unstructured":"Cooke JP (2000) Does ADMA cause endothelial dysfunction? Arterioscler Thromb Vasc Biol 20:2032\u20132037","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1362_CR9","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1365-2362.2007.01781.x","volume":"37","author":"D Ardigo","year":"2007","unstructured":"Ardigo D, St\u00fcehlinger M, Franzini L et al (2007) ADMA is independently related to flow-mediated vasodilation in subjects at low cardiovascular risk. Eur J Clin Invest 37:263\u2013269","journal-title":"Eur J Clin Invest"},{"key":"1362_CR10","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1210\/jc.2006-2643","volume":"92","author":"AE Altinova","year":"2007","unstructured":"Altinova AE, Arslan M, Sepici-Dincel A, Akturk M, Altan N, Toruner FB (2007) Uncomplicated type 1 diabetes is associated with increased asymmetric dimethylarginine concentrations. J Clin Endocrinol Metab 92:1881\u20131885","journal-title":"J Clin Endocrinol Metab"},{"key":"1362_CR11","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/S0002-9149(01)02063-X","volume":"88","author":"F Abbasi","year":"2001","unstructured":"Abbasi F, Asagmi T, Cooke JP et al (2001) Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus. Am J Cardiol 88:1201\u20131203","journal-title":"Am J Cardiol"},{"key":"1362_CR12","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.2337\/dc07-0019","volume":"30","author":"K Krzyzanowska","year":"2007","unstructured":"Krzyzanowska K, Mittermayer F, Wolzt M, Schernthaner G (2007) Asymmetric dimethylarginine predicts cardiovascular events in patients with type 2 diabetes. Diabetes Care 30:1834\u20131839","journal-title":"Diabetes Care"},{"key":"1362_CR13","doi-asserted-by":"crossref","first-page":"110","DOI":"10.5493\/wjem.v5.i2.110","volume":"5","author":"H Konya","year":"2015","unstructured":"Konya H, Miuchi M, Satani K et al (2015) Asymmetric dimethylarginine, a biomarker of cardiovascular complications in diabetes mellitus. World J Exp Med 5:110\u2013119","journal-title":"World J Exp Med"},{"key":"1362_CR14","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1681\/ASN.2005010063","volume":"16","author":"RJ Johnson","year":"2005","unstructured":"Johnson RJ, Segal MS, Srinivas T et al (2005) Essential hypertension, progressive renal disease, and uric acid: a pathogenetic link? J Am Soc Nephrol 16:1909\u20131919","journal-title":"J Am Soc Nephrol"},{"key":"1362_CR15","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMra0800885","volume":"359","author":"DI Feig","year":"2008","unstructured":"Feig DI, Kang DH, Johnson RJ (2008) Uric acid and cardiovascular risk. N Engl J Med 359:1811\u20131821","journal-title":"N Engl J Med"},{"key":"1362_CR16","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.2337\/db10-0916","volume":"60","author":"W Baldwin","year":"2011","unstructured":"Baldwin W, McRae S, Marek G et al (2011) Hyperuricemia as a mediator of the proinflammatory endocrine imbalance in the adipose tissue in a murine model of the metabolic syndrome. Diabetes 60:1258\u20131269","journal-title":"Diabetes"},{"key":"1362_CR17","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1056\/NEJM198501173120305","volume":"312","author":"JM McCord","year":"1985","unstructured":"McCord JM (1985) Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 312:159\u2013163","journal-title":"N Engl J Med"},{"key":"1362_CR18","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/sj.mn.7800136","volume":"9","author":"A Meneshian","year":"2002","unstructured":"Meneshian A, Bulkley GB (2002) The physiology of endothelial xanthine oxidase: from urate catabolism to reperfusion injury to inflammatory signal transduction. Microcirculation 9:161\u2013175","journal-title":"Microcirculation"},{"issue":"Pt 3","key":"1362_CR19","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1113\/jphysiol.2003.055913","volume":"555","author":"CE Berry","year":"2004","unstructured":"Berry CE, Hare JM (2004) Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications. J Physiol 555(Pt 3):589\u2013606","journal-title":"J Physiol"},{"key":"1362_CR20","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1111\/j.1464-5491.2005.01630.x","volume":"22","author":"UR Kuppusamy","year":"2005","unstructured":"Kuppusamy UR, Indran M, Rokiah P (2005) Glycaemic control in relation to xanthine oxidase and antioxidant indices in Malaysian Type 2 diabetes patients. Diabet Med 22:1343\u20131346","journal-title":"Diabet Med"},{"key":"1362_CR21","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.2337\/diabetes.51.4.1118","volume":"51","author":"MC Desco","year":"2002","unstructured":"Desco MC, Asensi M, M\u00e1rquez R et al (2002) Xanthine oxidase is involved in free radical production in type 1 diabetes: protection by allopurinol. Diabetes 51:1118\u20131124","journal-title":"Diabetes"},{"key":"1362_CR22","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1161\/01.CIR.0000056762.69302.46","volume":"107","author":"S Spiekermann","year":"2003","unstructured":"Spiekermann S, Landmesser U, Dikalov S et al (2003) Electron spin resonance characterization of vascular xanthine and NAD(P)H oxidase activity in patients with coronary artery disease: relation to endothelium-dependent vasodilation. Circulation 107:1383\u20131389","journal-title":"Circulation"},{"key":"1362_CR23","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.metabol.2017.01.031","volume":"70","author":"KW Washio","year":"2017","unstructured":"Washio KW, Kusunoki Y, Murase T et al (2017) Xanthine oxidoreductase activity is correlated with insulin resistance and subclinical inflammation in young humans. Metabolism 70:51\u201356","journal-title":"Metabolism"},{"key":"1362_CR24","first-page":"1","volume":"32","author":"K Nomura","year":"2015","unstructured":"Nomura K, Masuda H, Sano K, Koyama T, Suzuki H, Hontani H (2015) Automatic artery extraction in ultrasound images for the aid of FMD test. IEICE Tech Rep 32:1\u20136","journal-title":"IEICE Tech Rep"},{"key":"1362_CR25","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jchromb.2016.10.033","volume":"1039","author":"T Murase","year":"2016","unstructured":"Murase T, Nampei M, Oka M, Miyachi A, Nakamura T (2016) A highly sensitive assay of human plasma xanthine oxidoreductase activity using stable isotope-labeled xanthine and LC\/TQMS. J Chromatogr B Analyt Technol Biomed Life Sci 1039:51\u201358","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"1362_CR26","doi-asserted-by":"crossref","first-page":"e002270","DOI":"10.1161\/JAHA.115.002270","volume":"4","author":"Y Matsuzawa","year":"2015","unstructured":"Matsuzawa Y, Kwon TG, Lennon RJ, Lerman LO, Lerman A (2015) Prognostic value of flow-mediated vasodilation in brachial artery and fingertip artery for cardiovascular events: a systematic review and meta-analysis. J Am Heart Assoc 4:e002270","journal-title":"J Am Heart Assoc"},{"key":"1362_CR27","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3109\/0886022X.2014.882240","volume":"36","author":"M Boban","year":"2014","unstructured":"Boban M, Kocic G, Radenkovic S et al (2014) Circulating purine compounds, uric acid, and xanthine oxidase\/dehydrogenase relationship in essential hypertension and end stage renal disease. Ren Fail 36:613\u2013618","journal-title":"Ren Fail"},{"key":"1362_CR28","doi-asserted-by":"crossref","first-page":"8745","DOI":"10.1073\/pnas.93.16.8745","volume":"93","author":"CR White","year":"1996","unstructured":"White CR, Darley-Usmar V, Berrington WR et al (1996) Circulating plasma xanthine oxidase contributes to vascular dysfunction in hypercholesterolemic rabbits. Proc Natl Acad Sci USA 93:8745\u20138749","journal-title":"Proc Natl Acad Sci USA"},{"key":"1362_CR29","doi-asserted-by":"crossref","first-page":"15416","DOI":"10.1038\/s41598-017-15419-0","volume":"7","author":"A Nakatani","year":"2017","unstructured":"Nakatani A, Nakatani S, Ishimura E et al (2017) Xanthine oxidoreductase activity is associated with serum uric acid and glycemic control in hemodialysis patients. Sci Rep 7:15416","journal-title":"Sci Rep"},{"key":"1362_CR30","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/jdi.12870","volume":"10","author":"S Sunagawa","year":"2019","unstructured":"Sunagawa S, Shirakura T, Hokama N et al (2019) Activity of xanthine oxidase in plasma correlates with indices of insulin resistance and liver dysfunction in patients with type 2 diabetes mellitus and metabolic syndrome: a pilot exploratory study. J Diabetes Investig 10:94\u2013103","journal-title":"J Diabetes Investig"},{"key":"1362_CR31","doi-asserted-by":"crossref","first-page":"587083","DOI":"10.1155\/2014\/587083","volume":"2014","author":"AM Feoli","year":"2014","unstructured":"Feoli AM, Macagnan FE, Piovesan CH, Bodanese LC, Siqueira IR (2014) Xanthine oxidase activity is associated with risk factors for cardiovascular disease and inflammatory and oxidative status markers in metabolic syndrome: effects of a single exercise session. Oxid Med Cell Longev 2014:587083","journal-title":"Oxid Med Cell Longev"},{"key":"1362_CR32","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jri.2016.06.002","volume":"116","author":"H Is\u0131k","year":"2016","unstructured":"Is\u0131k H, Ayn\u0131oglu O, T\u0131mur H et al (2016) Is Xanthine oxidase activity in polycystic ovary syndrome associated with inflammatory and cardiovascular risk factors? J Reprod Immunol 116:98\u2013103","journal-title":"J Reprod Immunol"},{"key":"1362_CR33","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1089\/chi.2015.0051","volume":"12","author":"HK Tam","year":"2016","unstructured":"Tam HK, Kelly AS, Fox CK, Nathan BM, Johnson LA (2016) Weight loss mediated reduction in xanthine oxidase activity and uric acid clearance in adolescents with severe obesity. Child Obes 12:286\u2013291","journal-title":"Child Obes"},{"key":"1362_CR34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/0145721709333493","volume":"35","author":"G Scheiner","year":"2009","unstructured":"Scheiner G, Sobel RJ, Smith DE et al (2009) Insulin pump therapy guidelines for successful outcomes. Diabetes Educ 35:1\u201312","journal-title":"Diabetes Educ"},{"key":"1362_CR35","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/1475-2840-11-145","volume":"11","author":"B Rathsman","year":"2012","unstructured":"Rathsman B, Rosfors S, Sj\u00f6holm A, Nystr\u00f6m T (2012) Early signs of atherosclerosis are associated with insulin resistance in non-obese adolescent and young adults with type 1 diabetes. Cardiovasc Diabetol 11:145","journal-title":"Cardiovasc Diabetol"},{"key":"1362_CR36","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/0140-6736(92)93147-F","volume":"340","author":"DS Celermajer","year":"1992","unstructured":"Celermajer DS, Sorensen KE, Gooch VM et al (1992) Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340:1111\u20131115","journal-title":"Lancet"},{"key":"1362_CR37","doi-asserted-by":"crossref","first-page":"589","DOI":"10.5551\/jat.11973","volume":"19","author":"L Stoner","year":"2012","unstructured":"Stoner L, Erickson ML, Young JM et al (2012) There\u2019s more to flow-mediated dilation than nitric oxide. J Atheroscler Thromb 19:589\u2013600","journal-title":"J Atheroscler Thromb"},{"key":"1362_CR38","doi-asserted-by":"crossref","first-page":"9265","DOI":"10.1073\/pnas.84.24.9265","volume":"84","author":"LJ Ignarro","year":"1987","unstructured":"Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G (1987) Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 84:9265\u20139269","journal-title":"Proc Natl Acad Sci USA"},{"key":"1362_CR39","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.1074\/jbc.274.8.4985","volume":"274","author":"M Houston","year":"1999","unstructured":"Houston M, Estevez A, Chumley P et al (1999) Binding of xanthine oxidase to vascular endothelium. Kinetic characterization and oxidative impairment of nitric oxide-dependent signaling. J Biol Chem 274:4985\u20134994","journal-title":"J Biol Chem"},{"key":"1362_CR40","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1161\/01.CIR.0000124725.46165.2C","volume":"109","author":"MJ J\u00e4rvisalo","year":"2004","unstructured":"J\u00e4rvisalo MJ, Raitakari M, Toikka JO et al (2004) Endothelial dysfunction and increased arterial intima-media thickness in children with type 1 diabetes. Circulation 109:1750\u20131755","journal-title":"Circulation"},{"key":"1362_CR41","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1590\/2359-3997000000271","volume":"61","author":"AMMAD Nascimento","year":"2017","unstructured":"Nascimento AMMAD, Sequeira IJ, Vasconcelos DF, Gandolfi L, Pratesi R, N\u00f3brega YKM (2017) Endothelial dysfunction in children with type 1 diabetes mellitus. Arch Endocrinol Metab 61:476\u2013483","journal-title":"Arch Endocrinol Metab"},{"key":"1362_CR42","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1161\/01.CIR.0000046448.26751.58","volume":"107","author":"S Guthikonda","year":"2003","unstructured":"Guthikonda S, Sinkey C, Barenz T, Haynes WG (2003) Xanthine oxidase inhibition reverses endothelial dysfunction in heavy smokers. Circulation 107:416\u2013421","journal-title":"Circulation"},{"key":"1362_CR43","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1161\/01.HYP.35.3.746","volume":"35","author":"R Butler","year":"2000","unstructured":"Butler R, Morris AD, Belch JJ, Hill A, Struthers AD (2000) Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension. Hypertension 35:746\u2013751","journal-title":"Hypertension"},{"key":"1362_CR44","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1475-2840-11-2","volume":"11","author":"S Takayama","year":"2012","unstructured":"Takayama S, Kawamoto R, Kusunoki T, Abe M, Onji M (2012) Uric acid is an independent risk factor for carotid atherosclerosis in a Japanese elderly population without metabolic syndrome. Cardiovasc Diabetol 11:2","journal-title":"Cardiovasc Diabetol"},{"key":"1362_CR45","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s00592-014-0611-1","volume":"51","author":"P Bjornstad","year":"2014","unstructured":"Bjornstad P, Maahs DM, Rivard CJ et al (2014) Serum uric acid predicts vascular complications in adults with type 1 diabetes: the coronary artery calcification in type 1 diabetes study. Acta Diabetol 51:783\u2013791","journal-title":"Acta Diabetol"},{"key":"1362_CR46","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1161\/CIRCULATIONAHA.106.651117","volume":"114","author":"J George","year":"2006","unstructured":"George J, Carr E, Davies J, Belch JJ, Struthers A (2006) High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid. Circulation 114:2508\u20132516","journal-title":"Circulation"},{"key":"1362_CR47","first-page":"967","volume":"79","author":"N Linder","year":"1999","unstructured":"Linder N, Rapola J, Raivio KO (1999) Cellular expression of xanthine oxidoreductase protein in normal human tissues. Lab Invest 79:967\u2013974","journal-title":"Lab Invest"},{"issue":"Pt 2","key":"1362_CR48","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1042\/bj2890523","volume":"289","author":"T Adachi","year":"1993","unstructured":"Adachi T, Fukushima T, Usami Y, Hirano K (1993) Binding of human xanthine oxidase to sulphated glycosaminoglycans on the endothelial-cell surface. Biochem J 289(Pt 2):523\u2013527","journal-title":"Biochem J"},{"key":"1362_CR49","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1006\/bbrc.1996.5983","volume":"230","author":"S Sakuma","year":"1997","unstructured":"Sakuma S, Fujimoto Y, Sakamoto Y et al (1997) Peroxynitrite induces the conversion of xanthine dehydrogenase to oxidase in rabbit liver. Biochem Biophys Res Commun 230:476\u2013479","journal-title":"Biochem Biophys Res Commun"},{"key":"1362_CR50","doi-asserted-by":"crossref","first-page":"E924","DOI":"10.1152\/ajpendo.2001.281.5.E924","volume":"281","author":"A Risso","year":"2001","unstructured":"Risso A, Mercuri F, Quagliaro L, Damante G, Ceriello A (2001) Intermittent high glucose enhances apoptosis in human umbilical vein endothelial cells in culture. Am J Physiol Endocrinol Metab 281:E924\u2013E930","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1362_CR51","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1001\/jama.295.14.1681","volume":"295","author":"L Monnier","year":"2006","unstructured":"Monnier L, Mas E, Ginet C et al (2006) Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 295:1681\u20131687","journal-title":"JAMA"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-019-01362-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00592-019-01362-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-019-01362-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T23:43:18Z","timestamp":1589413398000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00592-019-01362-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,15]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["1362"],"URL":"https:\/\/doi.org\/10.1007\/s00592-019-01362-1","relation":{},"ISSN":["0940-5429","1432-5233"],"issn-type":[{"value":"0940-5429","type":"print"},{"value":"1432-5233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,15]]},"assertion":[{"value":"28 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the 1975 Declaration of Helsinki, as revised in 2008 (5).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}},{"value":"Informed consent was obtained from all patients that participated in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}